Article Versions Notes

Cho YA, Ko SY, Suh YJ, Kim S, Park JH, Park H-R, Seo J, Choi HG, Kang HS, Lim H, et al. PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy. Current Oncology. 2022; 29(5):2895-2908. https://doi.org/10.3390/curroncol29050236

Cho, Yoon Ah, Seung Yeon Ko, Yong Joon Suh, Sanghwa Kim, Jung Ho Park, Hye-Rim Park, Jinwon Seo, Hyo Geun Choi, Ho Suk Kang, Hyun Lim, and et al. 2022. "PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy" Current Oncology 29, no. 5: 2895-2908. https://doi.org/10.3390/curroncol29050236

Cho, Y. A., Ko, S. Y., Suh, Y. J., Kim, S., Park, J. H., Park, H.-R., Seo, J., Choi, H. G., Kang, H. S., Lim, H., Park, H. Y., & Kwon, M. J. (2022). PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy. Current Oncology, 29(5), 2895-2908. https://doi.org/10.3390/curroncol29050236